Featured Research

from universities, journals, and other organizations

Compound That Frees Trapped Cholesterol Identified

Date:
January 30, 2009
Source:
UT Southwestern Medical Center
Summary:
Researchers have identified in mice a compound that liberates cholesterol that has inappropriately accumulated to excessive levels inside cells.

Dr. John Dietschy (right), along with colleagues Drs. Benny Liu and Joyce Repa, have identified a compound that liberates cholesterol that has inappropriately accumulated to excessive levels inside cells. This cholesterol accumulation is a characteristic of Niemann-Pick type C disease.
Credit: Image courtesy of UT Southwestern Medical Center

Researchers at UT Southwestern Medical Center have identified in mice a compound that liberates cholesterol that has inappropriately accumulated to excessive levels inside cells.

Related Articles


The findings shed light on how cholesterol is transported through the cells of the body and suggest a possible therapeutic target for Niemann-Pick type C disease (NP-C), an inherited neurodegenerative disorder characterized by abnormally high cholesterol levels in every organ.

“What we’ve shown is that very quickly after administration of this compound, the huge pool of cholesterol that has just been accumulating in the cells is suddenly released and metabolized normally,” said Dr. John Dietschy, professor of internal medicine at UT Southwestern and senior author of the study appearing online this week and in an upcoming issue of the Proceedings of the National Academy of Sciences. “With just one dose, you excrete a large portion of this pool of cholesterol.”

Cholesterol in the body comes from dietary sources and is also made by the body itself. It is essential for many biological processes, including the construction and maintenance of cell membranes. Cholesterol normally is transported through cells and is excreted by the body.

People with Niemann-Pick type C have a genetic mutation that causes excessive amounts of cholesterol to accumulate in compartments within cells called lysosomes. This cholesterol accumulation leads to liver disease, neurodegeneration and dementia. There is no specific level at which cholesterol levels become abnormal, but the vast majority of children diagnosed with NP-C die before they are 20 years old and many before age 10. Late onset of neurological symptoms such as clumsiness, mild retardation and delayed development of fine motor skills can lead to longer life spans, but few people diagnosed with NP-C reach age 40.

In the current research, researchers injected a single dose of a cholesterol-binding agent known as CYCLO into 7-day-old mice with the Niemann-Pick mutation. Shortly after administration, the mice that received CYCLO began to process cholesterol just as their healthy counterparts did. After 49 days, the mice treated with a single injection continued to show substantially lower tissue cholesterol levels than the untreated mice, as well as improved liver function and decreased neurodegeneration.

Dr. Dietschy, who has been studying cholesterol metabolism for nearly 50 years, cautioned that the findings in no way represent a Niemann-Pick disease cure.

“The key idea is that we appear to have overcome the transport defect in the lysosome that is brought about by the genetic defect or mutation,” Dr. Dietschy said. “We do not yet understand what is happening at the molecular level, but it is clear that this compound somehow overcomes the genetic defect that causes individuals to accumulate cholesterol.”

The next step in Dr. Dietschy’s investigation is to determine the concentration of CYCLO needed to trigger the cholesterol’s release. Researchers also hope to determine in animals the additional lifespan CYCLO administration provides, as well as how long the drug’s affects lasts.

“By treating at seven days, we eliminated approximately one-third of the accumulated cholesterol almost immediately,” Dr. Dietschy said. “Now we want to see what happens if we give it every week. Can we maintain low cholesterol levels? That’s what we’re looking at now.”

Other UT Southwestern researchers involved in the research were Dr. Benny Liu, lead author of the study and postdoctoral researcher in internal medicine; Dr. Stephen Turley, professor of internal medicine; Dr. Dennis Burns, professor of pathology; Anna Miller, student research assistant; and Dr. Joyce Repa, assistant professor of physiology.

The work was funded by the U.S. Public Health Service, the Harry S. Moss Heart Trust, the Ara Parseghian Medical Research Foundation and the Dana’s Angels Research Trust.


Story Source:

The above story is based on materials provided by UT Southwestern Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

UT Southwestern Medical Center. "Compound That Frees Trapped Cholesterol Identified." ScienceDaily. ScienceDaily, 30 January 2009. <www.sciencedaily.com/releases/2009/01/090126173717.htm>.
UT Southwestern Medical Center. (2009, January 30). Compound That Frees Trapped Cholesterol Identified. ScienceDaily. Retrieved October 23, 2014 from www.sciencedaily.com/releases/2009/01/090126173717.htm
UT Southwestern Medical Center. "Compound That Frees Trapped Cholesterol Identified." ScienceDaily. www.sciencedaily.com/releases/2009/01/090126173717.htm (accessed October 23, 2014).

Share This



More Health & Medicine News

Thursday, October 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Fears Keep Guinea Hospitals Empty

Ebola Fears Keep Guinea Hospitals Empty

AP (Oct. 23, 2014) Fears of Ebola are keeping doctors and patients alike away from hospitals in the West African nation of Guinea. (Oct. 23) Video provided by AP
Powered by NewsLook.com
Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Working Mother (Oct. 22, 2014) Is your child ready? Video provided by Working Mother
Powered by NewsLook.com
U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

Newsy (Oct. 22, 2014) Now that the U.S. is restricting travel from West Africa, some are dropping questions about a travel ban and instead asking about visa bans. Video provided by Newsy
Powered by NewsLook.com
More People Diagnosed With TB In 2013, But There's Good News

More People Diagnosed With TB In 2013, But There's Good News

Newsy (Oct. 22, 2014) The World Health Organizations says TB numbers rose in 2013, but it's partly due to better detection and more survivors. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins